Brittany G. Craiglow, MD, FAAD

Brittany G. Craiglow, MD, FAAD, is a board-certified, fellowship-trained pediatric dermatologist and associate professor adjunct of dermatology at Yale School of Medicine. She also practices at Middlebury Dermatology in Connecticut.

Articles by Brittany G. Craiglow, MD, FAAD

Brittany G. Craiglow, MD, FAAD in part 3 of an AJMC interview

Closing Evidence Gaps in Managed Care for Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD

BySkylar Jeremias,Brittany G. Craiglow, MD, FAAD

August 17th 2026

An expert discusses gaps in pediatric alopecia areata evidence, missed trial outcomes, and what managed care should change for children with the disease.

Brittany G. Craiglow, MD, FAAD in part 2 of an AJMC Q&A

JAK Inhibitor Hesitancy and Step Therapy in Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD

BySkylar Jeremias,Brittany G. Craiglow, MD, FAAD

August 10th 2026

Brittany G. Craiglow, MD, FAAD, discusses JAK inhibitor hesitancy in pediatric alopecia areata, boxed warnings, and why step therapy falls short.

Brittany Craiglow, MD in part 1 of an AJMC Q&A

The Psychiatric Burden of Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD

BySkylar Jeremias,Brittany G. Craiglow, MD, FAAD

August 3rd 2026

Brittany G. Craiglow, MD, FAAD, discusses the psychiatric and psychosocial toll of alopecia in children and adolescents, and its impact on treatment initiation.

Brittany G. Craiglow, MD, FAAD

Articles by Brittany G. Craiglow, MD, FAAD

Closing Evidence Gaps in Managed Care for Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD

JAK Inhibitor Hesitancy and Step Therapy in Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD

The Psychiatric Burden of Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD

Latest Updated Articles

Trending on AJMC

5 Things to Know About the FDA's Peptide Reversal

Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial

FDA Approves First Orexin Agonist for Narcolepsy Type 1

Student Mental Health, Success Tied to Future Health and Affordability

A Multi-Country Needs Assessment on MCL and CLL Management